To find clinical trials near you:
Purpose: To identify potential biomarkers that may predict the development of Alzheimer's disease in people who carry an Alzheimer's mutation.
Purpose: To determine the safety and effectiveness of twice daily administration of Exendin-4 as a treatment for early-stage Alzheimer's disease or mild cognitive impairment.
Purpose: To determine whether intensive blood pressure lowering will reduce the incidence of all-cause dementia, reduce the decline of global cognitive function in key specific domains, and show changes in brain structure.
Purpose: To examine how brain imaging technology and other tests can be used to measure the progression of mild cognitive impairment (MCI) and early Alzheimer's disease (AD) in order to aid in the early detection of AD and in measuring the effectiveness of treatments in future clinical trials.
Purpose: To determine if resveratrol treatment can delay or alter the deterioration of memory and daily functioning in older adults with probable Alzheimer's disease.